Top Stories

‘Adverse event’ takes place during Bharat Biotech’s Covaxin trials. Here’s what the company has to say

Covaxin, developed by Bharat Biotech, is currently undergoing phase-3 trials. But an “adverse event” took place during the phase 1 trial of its coronavirus vaccine candidate in August, when a patient was hospitalised after receiving a dose of the COVID-19 vaccine. The matter, however, was not made public. 

Leave a Reply

Your email address will not be published. Required fields are marked *